DEA proposes rule to curb fentanyl abuse
DEA is proposing to consider ANPP as a precursor to fentanyl and to classify it as a Schedule II controlled substance.
Because there has been an unprecedented outbreak of hundreds of fentanyl-related overdoses in recent months, the Drug Enforcement Administration is proposing to designate a chemical used by clandestine laboratory operators to make fentanyl as an immediate precursor to the Schedule II controlled substance. In addition, DEA wants to classify the chemical as a Schedule II substance. The chemical in question is ANPP or 4-anilino-N-phenethyl-4-piperidine. The DEA
Pharmacists Play Unique Role in Advancing Health Equity for Patients With Chronic Disease
December 7th 2023A new study, outlined in a poster at ASHP Midyear 2023, identified 3 key themes associated with the ways in which pharmacists are positioned to advance health equity for patients with chronic diseases.
Assessing Financial Impacts of Pharmacist-Led Interventions in Pediatric Ambulatory Care
December 5th 2023According to a poster abstract presented at the ASHP Midyear Clinical Meeting & Exhibition, specialty pharmacy services were used for a variety of conditions that have been reported in adult populations.
